
Cancer and its treatment can induce zzso and objective evidence of diminished functional capacity encompassing physical fatigue and cognitive zzso zzso zzso the zzso of zzso was evaluated for treatment of zzso fatigue and cognitive zzso A randomized, zzso zzso zzso study evaluated the potential therapeutic effect and safety of zzso in the treatment of patients with zzso zzso Change from baseline in the zzso Assessment of zzso Illness zzso zzso zzso total score at Week 8 was the primary outcome zzso One hundred zzso patients zzso with breast and zzso zzso were zzso and zzso Compared with zzso zzso subjects demonstrated a significant improvement in fatigue symptoms at Week 8 in the zzso zzso and the Clinical Global zzso scores zzso without clinically relevant changes in zzso zzso zzso function was not significantly zzso There was a higher rate of study drug-related adverse events zzso zzso of 76 zzso zzso 22 of 78 zzso and a higher zzso rate because of zzso (8 of 76 zzso zzso 1 of 78 zzso in zzso subjects compared with zzso zzso The most commonly reported zzso independent of study drug relationship in zzso subjects were headache, zzso and dry mouth, and in zzso subjects were headache, zzso and zzso zzso produced significant improvement in fatigue in subjects previously treated with zzso zzso Further studies with zzso or other agents to explore treatment response in zzso fatigue should be zzso 

